Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

107.26
Delayed Data
As of 4:02pm ET
 +1.96 / +1.86%
Today’s Change
94.00
Today|||52-Week Range
128.46
+2.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues220.4M196.4M161.3M169.9M
 
 
 
 
 
Cost of Goods Sold49.4M48.7M41.0M40.8M
 
 
 
 
 
Depreciation And Amortization3.7M3.8M3.8M4.0M
 
 
 
 
 
 
Operating ExpensesGross Income167.3M143.9M116.5M125.1M
 
 
 
 
 
General Expenses38.3M42.1M38.9M36.3M
 
 
 
 
 
Research And Development18.0M19.9M14.7M18.0M
 
 
 
 
 
Total Operating Expenses91.4M94.6M83.7M81.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income129.0M101.8M77.6M88.8M
 
 
 
 
 
Extraordinary Charge0.00-92.0K0.000.00
 
 
Other Expenses31.5M-5.1M-17.5M-33.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income160.5M100.3M64.6M59.5M
 
 
 
 
 
Income Taxes-20.5M-17.3M-10.0M-6.9M
 
 
 
 
 
Minority Interest-94.0K-23.0K-58.0K-90.0K
 
 
 
 
 
Discontinued Operations-137.0K-38.0K-47.0K-145.0K
 
 
 
 
 
Net Income139.8M83.0M54.5M52.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.0M40.6M40.5M40.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.0M40.6M40.5M40.3M
 
 
 
 
 
 
Earnings Per ShareEPS$3.42$2.05$1.35$1.30
 
 
 
 
 
EPS Diluted$3.41$2.05$1.35$1.30